A detailed history of Artisan Partners Limited Partnership transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 365,832 shares of DNLI stock, worth $7.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
365,832
Previous 383,942 4.72%
Holding current value
$7.95 Million
Previous $8.24 Million 8.9%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$15.83 - $23.35 $286,681 - $422,868
-18,110 Reduced 4.72%
365,832 $7.51 Million
Q4 2023

Feb 12, 2024

SELL
$16.2 - $23.18 $367,416 - $525,722
-22,680 Reduced 5.58%
383,942 $8.24 Million
Q3 2023

Nov 09, 2023

SELL
$20.63 - $30.17 $209,621 - $306,557
-10,161 Reduced 2.44%
406,622 $8.39 Million
Q2 2023

Aug 10, 2023

SELL
$23.37 - $32.96 $160,832 - $226,830
-6,882 Reduced 1.62%
416,783 $12.3 Million
Q1 2023

May 11, 2023

SELL
$21.91 - $32.67 $263,095 - $392,301
-12,008 Reduced 2.76%
423,665 $9.76 Million
Q4 2022

Feb 10, 2023

SELL
$26.28 - $33.92 $195,207 - $251,957
-7,428 Reduced 1.68%
435,673 $12.1 Million
Q3 2022

Nov 10, 2022

SELL
$25.97 - $38.53 $197,060 - $292,365
-7,588 Reduced 1.68%
443,101 $13.6 Million
Q2 2022

Aug 12, 2022

SELL
$20.88 - $35.19 $1.53 Million - $2.58 Million
-73,442 Reduced 14.01%
450,689 $13.3 Million
Q1 2022

May 13, 2022

BUY
$29.0 - $47.27 $78,967 - $128,716
2,723 Added 0.52%
524,131 $16.9 Million
Q4 2021

Feb 11, 2022

SELL
$42.59 - $55.02 $1.26 Million - $1.63 Million
-29,579 Reduced 5.37%
521,408 $23.3 Million
Q3 2021

Nov 12, 2021

SELL
$48.48 - $78.23 $768,795 - $1.24 Million
-15,858 Reduced 2.8%
550,987 $27.8 Million
Q2 2021

Aug 12, 2021

BUY
$50.3 - $78.44 $49,243 - $76,792
979 Added 0.17%
566,845 $44.5 Million
Q1 2021

May 11, 2021

BUY
$53.8 - $81.53 $7.67 Million - $11.6 Million
142,513 Added 33.66%
565,866 $32.3 Million
Q4 2020

Feb 10, 2021

BUY
$36.89 - $93.56 $15.6 Million - $39.6 Million
423,353 New
423,353 $35.5 Million

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.92B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.